Evidence map›Paper›PMID 42120537›Full record

ArticlePediatric research2026

Lung biopsy findings and pulmonary function in children after allogeneic hematopoietic stem cell transplantation.

Elli-Maija Ukonmaanaho, Turkka Kirjavainen, Laura Martelius, Jouko Lohi, Riitta Karikoski, Minna Koskenvuo, Mervi Taskinen

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elli-Maija UkonmaanahoDivision of Paediatric Haematology and Oncology, Oulu University Hospital, Oulu, Finland. University of Helsinki, Helsinki, Finland. elli-maija.ukonmaanaho@pohde.fi.ORCID http://orcid.org/0000-0001-8436-3922
Turkka KirjavainenDivision of Paediatric Pulmonology, New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Laura MarteliusDivision of Radiology, New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Jouko LohiDivision of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Riitta KarikoskiDivision of Pathology, Helsinki University Hospital, Helsinki, Finland.
Minna KoskenvuoDivision of Paediatric Haematology and Oncology, Turku University Hospital, Turku, Finland. University of Helsinki, Helsinki, Finland.
Mervi TaskinenDivision of Haematology-Oncology and Stem Cell Transplantation, Children and Adolescents, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPulmonary complications are a major cause of morbidity after allogeneic hematopoietic stem cell transplantation (HSCT). Late-onset non-infectious pulmonary complications (LONIPCs), especially bronchiolitis obliterans syndrome (BOS), are difficult to diagnose, particularly in paediatric patients.

methodsIn this retrospective single-center study, 14 of 325 paediatric HSCT recipients (4.3%) who developed severe pulmonary symptoms between 1999 and 2016 were analyzed. Lung biopsies were correlated with high-resolution computed tomography (HRCT) and pulmonary function tests (PFTs). Fourteen postmortem biopsies from HSCT patients without pulmonary symptoms served as controls.

resultsHistology showed BOS in eight patients, cryptogenic organizing pneumonia (COP) in three, and interstitial fibrosis in three. None of the controls had findings suggestive of LONIPCs. All patients with BOS exhibited obstructive spirometry results, while restrictive changes occurred in COP and fibrosis. HRCT findings, including bronchial wall thickening and dilation, were frequent but non-specific. The incidence of LONIPCs and BOS was 4% and 2%, respectively.

conclusionsBOS was the most common late-onset pulmonary complication after paediatric HSCT. Obstructive PFT changes correlated well with histological BOS, whereas HRCT findings lacked specificity. Regular pulmonary function monitoring appears more reliable than imaging for early detection and may help prevent progression to irreversible lung disease. IMPACT: This study highlights the diagnostic value of combining functional and histological assessment in children after HSCT. Underscores the limitations of HRCT in detecting early BOS. Supports routine pulmonary function surveillance as a non-invasive strategy to improve long-term outcomes.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.